Verrucous psoriasis in a patient with chronic C hepatitis treated with interferon

Clinical Drug Investigation

Volumn 24, Issue 7, 2004, Pages 427-429

  Scavo, Sebastiano ^a   Gurrera, Alessandra ^a   Mazzaglia, Claudio ^a   Magro, Gaetano ^a   Pulvirenti, Davide ^a   Gozzo, Erika ^a   Neri, Sergio ^a,b  

^a UNIVERSITY OF CATANIA   (Italy)

^b Ospedale S Marta   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CHRONIC HEPATITIS; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE COURSE; DRUG EFFECT; DRUG WITHDRAWAL; FOLLOW UP; HEPATITIS C; HUMAN; HUMAN TISSUE; LABORATORY TEST; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSORIASIS; SKIN BIOPSY; TREATMENT OUTCOME; VERRUCOUS PSORIASIS;

EID: 3242732809     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200424070-00006     Document Type: Article

References (10)

1. EASL International Consensus Conference on Hepatitis C. Paris 26-28 Feb 1999. J Hepatol 1999; 30: 956-61
2. Asnis LA, Gaspari AA. Cutaneous reactions to recombinant cytokine therapy. J Am Acad Dermatol 1995; 33: 393-410
3. Paquet P, Pierard-Franchimont C, Arrese JE, et al. Cutaneous side effects of interferon. Rev Med Liege 2001 Oct; 56 (10): 699-702
4. Raani P, Ben-Bassat I. Immune mediated complications during interferon therapy in haematological patients. Acta Haematol 2002; 107 (3): 133-44
5. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1 (5): 431-5
6. Gilhar A, Ullmann Y, Kerner H, et al. Psoriasis is mediated by a cutaneous defect triggered by activated immunocytes: induction of psoriasis by cells with natural killer receptors. J Invest Dermatol 2002 Aug; 119 (2): 384-91
7. Yamamoto T, Nishioka K. Oral psoriasis in a patient with hepatitis C virus infection. Eur J Dermatol 2002; 12: 75-6
8. Ong PY, Hamid QA, Travers JB, et al. Decreased IL-15 may contribute to elevated IgE and acute inflammation in atopic dermatitis. J Immunol 2002 Jan 1; 168 (1): 505-10
9. Hardman JG, Limbird LE, Gilman AG. Goodman and Gilman's the pharmacological basis of therapeutics. 10th ed. Maidenhead, Berks: McGraw-Hill 2001
10. Lombardini F, Tallione E, Riente L, et al. Psoriatic arthritis with spinal involvement in a patient receiving α-interferon for chronic hepatitis C. Scand J Rheumatol 1997; 26 (1): 58-60